AMPH Amphastar Pharmaceuticals Inc

-1.19 (-2.6%)
Last Updated: 13:29:34
Delayed by 15 minutes

Register Free for Streaming Quotes & Tools

Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more.


Draw Mode:

Volume 195,911
Bid Price 44.53
Ask Price 44.58
News -
Day High 45.74


52 Week Range


Day Low 43.785
Company Name Stock Ticker Symbol Market Type
Amphastar Pharmaceuticals Inc AMPH NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-1.19 -2.6% 44.55 13:29:34
Open Price Low Price High Price Close Price Prev Close
45.42 43.785 45.74 45.74
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
3,424 195,911 $ 44.44 $ 8,706,297 - 26.76 - 67.66
Last Trade Time Type Quantity Stock Price Currency
13:29:47 1 $ 44.54 USD

Amphastar Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
2.18B 48.86M - 498.99M 91.39M 1.87 23.82
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Amphastar Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No AMPH Message Board. Create One! See More Posts on AMPH Message Board See More Message Board Posts

Historical AMPH Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week45.8848.0643.78546.17424,447-1.33-2.9%
1 Month54.4054.4043.78546.87651,891-9.85-18.11%
3 Months56.9467.6643.78552.66467,860-12.39-21.76%
6 Months37.5067.6635.6249.17455,9457.0518.8%
1 Year28.3767.6626.7643.02349,85216.1857.03%
3 Years20.3067.6616.9133.26307,86924.25119.46%
5 Years19.1267.6612.32528.75274,78725.43133.0%

Amphastar Pharmaceuticals Description

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically-challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.
Your Recent History
Amphastar ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now